Research And Development Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Amlodipine Bisoprolol, Atc C07fb07 for the Period February 1St, 2024 - Janu...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Brimonidine (Exclusively Edp), Atc S01ea05 for the Period February 1St, 202...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Azelastine Fluticasone, Atc R01ad28 for the Period February 1St, 2024 - Jan...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Teriparatide, Atc H05aa02 for the Period February 1St, 2024 - January 31St,...

Open House Drug Discount Agreements Therapy Allergens, Atc V01aa05

Dynamic Purchasing System Qualification for Diathermy Equipment.

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Mesalazine, Atc A07ec02 for the Period February 1St, 2024 - January 31St, 2...

Conclusion of a Non-Exclusive Framework Agreement for Inspections in the Field of Road Construction in the Open House Procedure of the West Branch, Published in 2022

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Fampridine (Exclusively N3), Atc N07xx07 for the Period February 1St, 2024...

Open House Drug Discount Agreements Therapy Allergens, Atc V01aa03